Veterinary Lab Automation Global Market Report 2023 Now Available, Covers Asia-Pacific, North America, Europe, and More

The veterinary lab automation market is experiencing robust growth, expanding from $1.26 billion in 2025 to $1.36 billion in 2026 at an 8.4% CAGR, with projections to reach $1.9 billion by 2030. Growth is driven by rising demand for rapid diagnostics, AI integration, companion animal care expansion, and robotic workflow adoption. North America leads the market while Asia-Pacific is positioned for rapid expansion.

07/13/2026, 7:32 AM • GlobeNewswire

ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS

Rosen Law Firm is notifying Zoetis Inc. investors who purchased securities between January 14, 2025 and May 6, 2026 of an important July 27, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Zoetis made false statements about market share and sales growth while failing to disclose weakening adoption of flagship products Librela and Simparica Trio, as well as market share losses in dermatology products due to FDA safety warnings and increased competition.

07/10/2026, 5:49 PM • GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors to Contact the Firm Before the July 27th Lead Plaintiff Deadline

A class action lawsuit has been filed against Zoetis, Inc. for allegedly making materially false and misleading statements regarding its business operations between January 14, 2025 and May 6, 2026. The complaint alleges the company failed to disclose weakening veterinarian adoption of its Librela product due to FDA safety warnings, significant market share losses in Simparica Trio to competitors, and declining market share for dermatology products Apoquel and Cytopoint. Investors have until July 27, 2026 to apply as lead plaintiff.

07/10/2026, 12:51 PM • GlobeNewswire

Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Glancy Prongay Wolke & Rotter LLP announced a securities fraud class action lawsuit against Zoetis Inc., alleging the company made materially false statements and failed to disclose material adverse facts about its business. The lawsuit covers investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026. The company's stock declined significantly following three earnings announcements that revealed weakened demand in its Companion Animal portfolio, increased competition, and reduced growth outlooks. The deadline to file a lead plaintiff motion is July 27, 2026.

07/06/2026, 1:48 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Zoetis Inc. alleging securities fraud for making materially false and misleading statements about its Companion Animal segment products. The complaint claims the company failed to disclose weakening veterinarian adoption of Librela due to FDA safety warnings, significant market share losses for Simparica Trio to lower-priced competitors, and declining market share for dermatology products Apoquel and Cytopoint. Investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026 are eligible to join the class action.

07/06/2026, 12:00 PM • GlobeNewswire

ZTS 截止日期提醒：全球頂級律師事務所 ROSEN 建議損失超過 10 萬美元的 Zoetis Inc. 投資者趕及對 ZTS 提出證券集體訴訟的重要截止日期前聘請律師

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Zoetis Inc. (NYSE: ZTS) on behalf of investors who purchased securities between January 14, 2025 and May 6, 2026. The lawsuit alleges that Zoetis made false and misleading statements about market share growth and product adoption while failing to disclose significant market share losses in key products including Librela, Simparica Trio, Apoquel, and Cytopoint due to increased competition and FDA safety warnings. The deadline to apply as lead plaintiff is July 27, 2026.

07/04/2026, 6:15 PM • GlobeNewswire

ZTS DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS

Rosen Law Firm has filed securities class action lawsuits against Zoetis Inc. and ChampionX Corporation. The Zoetis lawsuit alleges the company made false statements about market share and product adoption while failing to disclose weakening sales of key products like Librela and Simparica Trio due to safety concerns and increased competition. The lead plaintiff deadline for the Zoetis case is July 27, 2026.

07/04/2026, 6:15 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Zoetis Inc. alleging securities fraud. The complaint claims the company made false statements about its Companion Animal segment products, including Librela, Simparica Trio, Apoquel, and Cytopoint, while failing to disclose weakening veterinarian adoption, market share losses to competitors, and FDA safety concerns. Investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026 may be eligible to join the case.

07/02/2026, 12:00 PM • GlobeNewswire

ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm has filed a class action lawsuit against Zoetis Inc. for alleged securities fraud, claiming the company made false and misleading statements regarding its products. The lawsuit alleges that Zoetis failed to disclose weakening prescription growth for Librela following FDA safety warnings about neurological complications in dogs, as well as market share losses for its Trio, Apoquel, and Cytopoint products. Investors who purchased securities between January 14, 2025 and May 6, 2026 are encouraged to join the case.

07/02/2026, 10:32 AM • GlobeNewswire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX

Rosen Law Firm has filed securities class action lawsuits against Roblox Corporation, Zoetis Inc., and Graphic Packaging Holding Company. The firm is seeking lead plaintiffs and encouraging investors who suffered losses to join the litigation. The Roblox case alleges the company made false statements about organic growth potential while concealing material adverse facts regarding age verification rollout impacts.

07/01/2026, 5:45 PM • GlobeNewswire

ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS

Rosen Law Firm is notifying Zoetis Inc. investors of a securities class action lawsuit covering purchases between January 14, 2025 and May 6, 2026. The lawsuit alleges that Zoetis made false statements about market share and sales growth while failing to disclose weakening adoption of flagship products Librela and Simparica Trio, as well as market share losses in dermatology products. The lead plaintiff deadline is July 27, 2026.

07/01/2026, 5:43 PM • GlobeNewswire

GPK DEADLINE NOTICE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Graphic Packaging Holding Company Investors with Losses in Excess of $100K to Secure Counsel Before Important July 6 Deadline in Securities Class Action – GPK

Rosen Law Firm has filed securities class action lawsuits against Graphic Packaging Holding Company, Roblox Corporation, and Zoetis Inc., alleging that defendants made false or misleading statements regarding their business operations and financial performance. Investors with losses exceeding $100,000 are encouraged to join the class actions before upcoming deadlines.

07/01/2026, 5:34 PM • GlobeNewswire

PHREESIA DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHR

Rosen Law Firm is notifying investors in Phreesia, Roblox, and Zoetis of ongoing securities class action lawsuits. Phreesia investors who purchased stock between May 8, 2025 and March 30, 2026 are reminded of the July 13, 2026 lead plaintiff deadline. The lawsuit alleges that Phreesia made false statements regarding slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment.

07/01/2026, 5:23 PM • GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors that a Class Action Lawsuit Has Been Filed Against Zoetis and Encourages Investors to Contact the Firm Before the July 27th Deadline

A class action lawsuit has been filed against Zoetis, Inc. for allegedly making materially false and misleading statements regarding its business operations. The complaint alleges that Zoetis failed to disclose weakening veterinarian adoption of its Librela product due to FDA safety warnings, significant market share losses in Simparica Trio to competitors, and declining market share for dermatology products Apoquel and Cytopoint. Investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026 have until July 27, 2026 to apply as lead plaintiff.

06/29/2026, 5:48 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Zoetis Inc. alleging securities fraud for materially false and misleading statements regarding its Companion Animal segment products. The complaint claims the company failed to disclose weakening veterinarian adoption of Librela due to FDA safety warnings, significant market share losses for Simparica Trio to lower-priced competitors, and declining market share for dermatology products Apoquel and Cytopoint. Investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026 are eligible to join the class action, with a lead plaintiff deadline of July 27, 2026.

06/29/2026, 12:00 PM • GlobeNewswire